As discussed in chapter 1 the primary object of clinical trials of new drugs is generally to demonstrate efficacy rather than safety. However, a trial in human beings not at the same time adequately addressing safety is unethical, and the assessment of safety variables is an important element of the trial.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science + Business Media B.V.
About this chapter
Cite this chapter
(2009). The Analysis of Safety Data. In: Cleophas, T.J., Zwinderman, A.H., Cleophas, T.F., Cleophas, E.P. (eds) Statistics Applied to Clinical Trials. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-9523-8_3
Download citation
DOI: https://doi.org/10.1007/978-1-4020-9523-8_3
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-9522-1
Online ISBN: 978-1-4020-9523-8
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)